Montreux_bio_action__0000s_0003_michael_v3
Montreux_bio_action_michael_tablet_v2 Montreux_bio_action_michael_tablet_v2
Montreux
return to team

Michael Matly, M.D.

Managing Director

Dr. Matly is a Managing Director at Montreux Equity Partners bringing significant experience in the health services and technology sectors.

Dr. Matly has been actively involved in Montreux's late-stage investments in health services and technology. He currently serves on the boards of Kareo, Pure Life Renal, and Pulmonx. Previously, he represented Montreux on the board of MINDBODY Online (NASDAQ: MB). He supports or has supported a number of Montreux portfolio companies including Epirus Biopharmaceuticals (NASDAQ: EPRS), Pivot Medical (acquired by Stryker), and GC Aesthetics.

Before joining Montreux, Dr. Matly led Business Development and New Ventures at the Mayo Clinic Center for Innovation. Dr. Matly’s responsibilities included new venture incubation as well as new product development for Mayo Clinic’s consumer offerings. In addition, Dr. Matly led the development of a new funding and partnership initiative that linked cutting-edge digital health start-ups with Mayo Clinic. Dr. Matly built strategic initiatives between Mayo Clinic and Fortune 100 companies from the retail, consumer, payer, technology, communications, and food/nutrition sectors.

Dr. Matly is a founding advisor to Rock Health, a leading digital health incubator based in San Francisco. He has served as an advisor to a number of digital health and health services companies as well as investment funds. Dr. Matly brings extensive operational experience as the co-founder and CEO of HAYATI Healthcare, a Middle East patient financing company.

Dr. Matly completed his M.D. from the Mayo Clinic, M.B.A. from Harvard Business School, and B.S. from Cornell University.